FDA

• Skip to main content
• Skip to FDA Search
• Skip to in this section menu
• Skip to footer links

Topic Paragraphs See Complete List of FDA Reforms

FDA Seizes 7-OH Opioids to Protect American Consumers

The U.S. Food and Drug Administration, in coordination with the U.S. Department of Justice, announced today that the U.S. Marshals Service seized approximately 73,000 units of 7-hydroxymitragynine (7-OH) products—valued at roughly $1 million—from three firms in Missouri.

Read More

Food

Drugs

Medical Devices

Radiation-Emitting Products

Vaccines, Blood, and Biologics

Animal and Veterinary

Cosmetics

Tobacco Products

Report a Problem with an FDA Regulated Product

Dec 15

FDA Eliminates Major Barrier to Using Real-World Evidence in Drug and Device Application Reviews

Dec 15

FDA Proactively Awards National Priority Voucher Based on Strong Phase 3 Study Results

More Press Announcements Newsroom Meetings Testimony Speeches

Dec 12

Town Food Service Equipment Co., Inc. Recalls Aluminum Saucepans Because of Possible Health Risk

Food & Beverages

Dec 12

White Castle Frozen Food Division Recalls Frozen 4-Count Cartons of Original Sliders Due to Undeclared Milk and Soy

Food & Beverages

Dec 12

South Asian Food Inc. Issues Allergy Alert on Undeclared Peanuts in "Bengal King Jhal Chanachur "

Food & Beverages

More Recalls Market Withdrawals & Safety Alerts Subscribe to the Enforcement Report Mailing List Paragraph Header

FDA Encourages Development of New, Reliable Alternatives to Animal Testing in Sunscreen

FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing.

FDA Focuses on Closing the Clinical Trial Reporting Gap for Research Integrity

The FDA is committed to ensuring data transparency by promoting timely registration and reporting of results information to ClinicalTrials.gov.

FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program

ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making.

View More FDA Voices

Dec 15

Study of Sex Differences in the Clinical Evaluation of Medical Products

Drugs

Dec 15

Sponsor Responsibilities - Safety Reporting Requirements and Safety Assessment for IND and Bioavailability/Bioequivalence Studies

Drugs

Dec 15

Investigator Responsibilities – Safety Reporting for Investigational Drugs and Devices

Drugs

FDA Guidance Search

Jobs at FDA

Inspections and Compliance

MedWatch: Safety Alerts

Science & Research

FDA Organization

Import Program

Warning Letters

Combination Products

Criminal Investigations

Disposal of Unused Medicines

Emergency Preparedness

Back to Top Feedback